摘要
目的观察硝苯地平缓释片(Ⅰ)联合清肝降压胶囊治疗老年性高血压的疗效。方法将就诊的老年性高血压患者120例随机分为3组,每组40例,分别口服硝苯地平缓释片(Ⅰ)、清肝降压胶囊、硝苯地平缓释片(Ⅰ)联合清肝降压胶囊,比较治疗前后患者血压情况。结果治疗前3组血压无明显差异(P>0.05),治疗后均有所降低,且清肝降压胶囊联合硝苯地平缓释片(Ⅰ)组效果更明显(P<0.05)。结论硝苯地平缓释片(I)联合清肝降压胶囊对老年性高血压的降压效果明显优于单纯硝苯地平缓释片(Ⅰ)和清肝降压胶囊,疗效确切,安全性高,不良反应少。
Objeetlve Identify the efficiencies of efficacies of Nifedipine （Ⅰ） and Qingganjiangya capsule joint thera- py on elderly hypertensive patients. Methods Divided 120 elderly hypertensive outpatients randomly into 3 treatment groups, respectively, Nifedipine （Ⅰ） therapy group, Qingganjiangya capsule therapy group, Nifedipine （Ⅰ） and Qingganjiangya cap- sule joint therapy group, each group was 40 patients. And compared the patients＇blood pressure before and after treatment. Re- sults There was no signifieant difference （ P 〉 0. 05 ） on blood pressures among the three groups before treatment. The blood pressures of all treatment groups were decreased for some extents after treatment. However the effieieneies of Nifedipine （Ⅰ） and Qingganjiangya capsule joint therapy group appeared more effective （ P 〈 0. 05 ）. Conclusion Nifedipine （Ⅰ） and Qinggan- jiangya capsule joint therapy appeare more effective than Nifedipine （Ⅰ） or Qingganjiangya capsule, safer and less adverse reactions.
出处
《实用心脑肺血管病杂志》
2012年第4期645-646,共2页
Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
